Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study

INTRODUCTION: Aberrant expression of immunophenotypic markers is commonly found in patients of acute leukemia. T-ALL also shows aberrant markers such as CD13, CD33, CD117, CD10, and CD79a. Morphologically, T-ALL has been categorized into L1, L2, and L3 subtypes. Till now, no study has been done to c...

Full description

Bibliographic Details
Main Authors: Neha Garg, Mrinalini Kotru, Dilip Kumar, Rajesh Pathak, Meera Sikka
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-10-01
Series:Journal of Laboratory Physicians
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/JLP.JLP_35_18
id doaj-48ecba2886274741a30dcca0259b1dec
record_format Article
spelling doaj-48ecba2886274741a30dcca0259b1dec2020-11-25T03:31:00ZengThieme Medical and Scientific Publishers Pvt. Ltd.Journal of Laboratory Physicians0974-27270974-78262018-10-01100441041310.4103/JLP.JLP_35_18Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot studyNeha Garg0Mrinalini Kotru1Dilip Kumar2Rajesh Pathak3Meera Sikka4Departments of Pathology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, IndiaDepartments of Pathology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, IndiaDepartment of Pathology, Max Hospital Saket, New Delhi, IndiaDepartments of Pathology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, IndiaDepartments of Pathology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, IndiaINTRODUCTION: Aberrant expression of immunophenotypic markers is commonly found in patients of acute leukemia. T-ALL also shows aberrant markers such as CD13, CD33, CD117, CD10, and CD79a. Morphologically, T-ALL has been categorized into L1, L2, and L3 subtypes. Till now, no study has been done to correlate these markers with morphological features of T-ALL. This study aimed to correlate the expression of aberrant immunophenotypic markers with morphology in T-ALL. MATERIALS AND METHODS: All the cases of T-ALL diagnosed by flow cytometry over a period of 2½ year were taken out from the records of Hematology Section of Department of Pathology of University College of Medical Science and Guru Teg Bahadur Hospital and Max Hospital, Saket. Their peripheral blood smear was screened to correlate the morphology of blasts with the expression of aberrant markers. RESULTS: A total of 40 cases of T-ALL were identified during 2½ year period of our study. Morphological correlation was available for 23 cases. Aberrant expression of CD10 was present in 6 (35.3%) cases, CD79a in 9 (47.36%) cases, CD117 in 5 (42.28%) cases and myeloid antigen CD33 in 5 (38.46%) cases. CD117 and CD33-positive cases showed L2 morphology with the presence of convolutions, while cases with expression of CD79a had L1 morphology with absent-slight convolutions. CD10-positive cases had L1/L2 morphology with absent occasionally present convolutions. CONCLUSION: There seems to be an association of aberrant markers with L1 and L2 morphology. However, this needs to be tested for statistical significance on a larger sample size.http://www.thieme-connect.de/DOI/DOI?10.4103/JLP.JLP_35_18acute lymphoblastic leukemiaslymphoid cell neoplasmsneoplasiat cell neoplasms
collection DOAJ
language English
format Article
sources DOAJ
author Neha Garg
Mrinalini Kotru
Dilip Kumar
Rajesh Pathak
Meera Sikka
spellingShingle Neha Garg
Mrinalini Kotru
Dilip Kumar
Rajesh Pathak
Meera Sikka
Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study
Journal of Laboratory Physicians
acute lymphoblastic leukemias
lymphoid cell neoplasms
neoplasia
t cell neoplasms
author_facet Neha Garg
Mrinalini Kotru
Dilip Kumar
Rajesh Pathak
Meera Sikka
author_sort Neha Garg
title Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study
title_short Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study
title_full Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study
title_fullStr Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study
title_full_unstemmed Correlation of expression of aberrant immunophenotypic markers in T-ALL with its morphology: A pilot study
title_sort correlation of expression of aberrant immunophenotypic markers in t-all with its morphology: a pilot study
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
series Journal of Laboratory Physicians
issn 0974-2727
0974-7826
publishDate 2018-10-01
description INTRODUCTION: Aberrant expression of immunophenotypic markers is commonly found in patients of acute leukemia. T-ALL also shows aberrant markers such as CD13, CD33, CD117, CD10, and CD79a. Morphologically, T-ALL has been categorized into L1, L2, and L3 subtypes. Till now, no study has been done to correlate these markers with morphological features of T-ALL. This study aimed to correlate the expression of aberrant immunophenotypic markers with morphology in T-ALL. MATERIALS AND METHODS: All the cases of T-ALL diagnosed by flow cytometry over a period of 2½ year were taken out from the records of Hematology Section of Department of Pathology of University College of Medical Science and Guru Teg Bahadur Hospital and Max Hospital, Saket. Their peripheral blood smear was screened to correlate the morphology of blasts with the expression of aberrant markers. RESULTS: A total of 40 cases of T-ALL were identified during 2½ year period of our study. Morphological correlation was available for 23 cases. Aberrant expression of CD10 was present in 6 (35.3%) cases, CD79a in 9 (47.36%) cases, CD117 in 5 (42.28%) cases and myeloid antigen CD33 in 5 (38.46%) cases. CD117 and CD33-positive cases showed L2 morphology with the presence of convolutions, while cases with expression of CD79a had L1 morphology with absent-slight convolutions. CD10-positive cases had L1/L2 morphology with absent occasionally present convolutions. CONCLUSION: There seems to be an association of aberrant markers with L1 and L2 morphology. However, this needs to be tested for statistical significance on a larger sample size.
topic acute lymphoblastic leukemias
lymphoid cell neoplasms
neoplasia
t cell neoplasms
url http://www.thieme-connect.de/DOI/DOI?10.4103/JLP.JLP_35_18
work_keys_str_mv AT nehagarg correlationofexpressionofaberrantimmunophenotypicmarkersintallwithitsmorphologyapilotstudy
AT mrinalinikotru correlationofexpressionofaberrantimmunophenotypicmarkersintallwithitsmorphologyapilotstudy
AT dilipkumar correlationofexpressionofaberrantimmunophenotypicmarkersintallwithitsmorphologyapilotstudy
AT rajeshpathak correlationofexpressionofaberrantimmunophenotypicmarkersintallwithitsmorphologyapilotstudy
AT meerasikka correlationofexpressionofaberrantimmunophenotypicmarkersintallwithitsmorphologyapilotstudy
_version_ 1724574338141650944